LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients

LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients

So far, studies about targeted therapies and predictive biomarkers for vulva carcinomas are rare. The leucine zipper downregulated in cancer 1 gene (LDOC1) has been identified in various carcinomas as a tumor-relevant protein influencing patients’ survival and prognosis. Due to the lack of informati...

Full description

Bibliographic Details
Main Authors: Giulia Wanka, Elisa Schmoeckel, Doris Mayr, Sophie Fuerst, Christina Kuhn, Sven Mahner, Julia Knabl, Maria Margarete Karsten, Christian Dannecker, Helene H. Heidegger, Aurelia Vattai, Udo Jeschke, Julia Jueckstock
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
vulvar carcinoma
LDOC1
cancer survival
prognosis
NF-κB
C-DIM 12
Online Access:https://www.mdpi.com/1422-0067/21/23/9287

Internet

https://www.mdpi.com/1422-0067/21/23/9287

Similar Items